Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Adtalem Global Education Inc. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This activity is situated within 1 distinct art unit, reflecting a concentrated effort in a specific technical domain. The presence of a distinct examiner indicates that the company's current prosecution pipeline is handled by a single individual at the USPTO. This centralized approach can facilitate a more consistent prosecution strategy, as the applicant only needs to address the concerns of one examiner in the assigned department.
SWITZER, JULIET CAROLINE is the busiest examiner for the portfolio, holding the pending office action. Since there is only a single examiner and 1 distinct art unit involved, the prosecution strategy is streamlined. The company's advancement in the Biotechnology & Pharmaceuticals field currently hinges on the resolution of this single office action, making the relationship with this specific examiner the central focus of their patenting activity. Practitioners should prioritize clear communication and technical precision to successfully navigate the pending matter.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SWITZER, JULIET CAROLINE | 1 | 42.6% | +53.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18106394 | METHODS OF DETECTING TRICHOMONAS TENAX | SWITZER, JULIET CAROLINE | 17d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18106394 | METHODS OF DETECTING TRICHOMONAS TENAX | SWITZER, JULIET CAROLINE | 17d overdue |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18106394 | METHODS OF DETECTING TRICHOMONAS TENAX | SWITZER, JULIET CAROLINE | 1682 | §103§112 | Final Rejection | 17d overdue | Pending | Feb 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAdtalem Global Education Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Juliet Caroline Switzer has the most, with 1 of Adtalem Global Education Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.